- Report
- October 2024
- 93 Pages
Global
From €5340EUR$5,600USD£4,463GBP
- Report
- October 2024
- 297 Pages
Global
From €4721EUR$4,950USD£3,945GBP
- Report
- October 2024
- 203 Pages
Global
From €5197EUR$5,450USD£4,343GBP
- Report
- July 2024
- 139 Pages
Global
From €3718EUR$3,899USD£3,107GBP
- Report
- January 2024
- 200 Pages
Global
From €4768EUR$5,000USD£3,985GBP
- Report
- January 2024
- 200 Pages
Global
From €4768EUR$5,000USD£3,985GBP
- Report
- November 2023
- 400 Pages
Global
From €4768EUR$5,000USD£3,985GBP
- Report
- November 2023
- 250 Pages
Global
From €4768EUR$5,000USD£3,985GBP
- Report
- February 2024
- 111 Pages
Global
From €4530EUR$4,750USD£3,786GBP
- Report
- August 2024
- 180 Pages
Global
From €4673EUR$4,900USD£3,905GBP
- Report
- February 2024
- 143 Pages
Global
From €4530EUR$4,750USD£3,786GBP
- Report
- February 2024
- 110 Pages
Global
From €4530EUR$4,750USD£3,786GBP
- Report
- February 2024
- 115 Pages
Global
From €4530EUR$4,750USD£3,786GBP
- Report
- August 2024
- 150 Pages
Global
From €3576EUR$3,750USD£2,989GBP
- Report
- July 2024
- 150 Pages
Global
From €3576EUR$3,750USD£2,989GBP
- Report
- February 2024
- 197 Pages
Global
From €4625EUR$4,850USD£3,865GBP
- Report
- March 2024
- 200 Pages
Global
From €3958EUR$4,150USD£3,307GBP
- Report
- January 2024
- 200 Pages
Global
From €3958EUR$4,150USD£3,307GBP
- Report
- February 2024
- 96 Pages
North America
From €4530EUR$4,750USD£3,786GBP
- Report
- January 2023
- 87 Pages
Global
From €4721EUR$4,950USD£3,945GBP
The Cardiac Rhythm Management (CRM) market is a segment of the cardiovascular devices industry. It includes a range of products and services used to diagnose and treat cardiac arrhythmias, or abnormal heart rhythms. These products include pacemakers, implantable cardioverter defibrillators (ICDs), cardiac resynchronization therapy (CRT) devices, and cardiac ablation systems. CRM products are used to monitor and regulate the electrical activity of the heart, helping to restore normal rhythm and improve patient outcomes.
CRM products are used in a variety of clinical settings, including hospitals, clinics, and ambulatory care centers. The market is driven by technological advancements, such as miniaturization of devices and the development of new features, as well as an increasing prevalence of cardiovascular diseases.
Notable companies in the CRM market include Medtronic, Abbott, Boston Scientific, Biotronik, and LivaNova. Show Less Read more